Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Review which Dividend Aristocrats ETF has the highest management fee and how it affects net performance.
28,021 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Analysts warn that Iran could use control of key internet cables as a new economic lever, risking a wave of volatilit...
Nvidia remains the AI chip leader, but Broadcom and Marvell are gaining ground as hyperscalers push for lower costs t...
Oil prices push higher as supply fears mount, triggering a broad debt selloff and jittery stock futures. Iran tension...
IBM is attracting fresh investor attention as its AI infrastructure strategy gains traction. Arvind Krishna’s reshape...
As toyota's challenging u.s. business tests the automaker, investors watch for strategies that could yield a Maverick...
SoFi has surprised some investors by turning a key profitability metric into a clear strength. This article breaks do...
A leaked Meta audio from an April 30 all-hands meeting signals a shift toward leveraging compute and internal output ...
Credo Technology stock sits near its 52-week peak as AI infrastructure demand remains robust. Investors are debating ...
Retail investors are retreating from crypto while institutions step up exposure, reshaping liquidity and risk. The sh...
Oracle enters a critical earnings season with eyes on its AI pivot and data-center expansion. The market has piled on...
Nu Holdings has fallen sharply, with the stock down 37% from its 52-week high. This guide explains what an investor s...